相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pharmacokinetics, Pharmacodynamics, and Tolerability of GS-9851, a Nucleotide Analog Polymerase Inhibitor, following Multiple Ascending Doses in Patients with Chronic Hepatitis C Infection
Eric Lawitz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
A new standard of care for the treatment of chronic HCV infection
Wolf Peter Hofmann et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2011)
PSI-7851, a Pronucleotide of β-D-2′-Deoxy-2′-Fluoro-2′-C-Methyluridine Monophosphate, Is a Potent and Pan-Genotype Inhibitor of Hepatitis C Virus Replication
Angela M. Lam et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Adverse effects of drugs in the treatment of viral hepatitis
Francesco Negro
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2010)
Emerging therapies for hepatitis C virus
Aybike Birerdinc et al.
EXPERT OPINION ON EMERGING DRUGS (2010)
Mechanism of Activation of PSI-7851 and Its Diastereoisomer PSI-7977
Eisuke Murakami et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Discovery of a β-D-2′-Deoxy-2′-α-fluoro-2′-β-C-methyluridine Nucleotide Prodrug (PSI-7977) for the Treatment of Hepatitis C Virus
Michael J. Sofia et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
HCV drug discovery aimed at viral eradication
R. F. Schinazi et al.
JOURNAL OF VIRAL HEPATITIS (2010)
Treatment of Hepatitis C Virus Infection With Interferon and Small Molecule Direct Antivirals: Viral Kinetics and Modeling
Libin Rong et al.
CRITICAL REVIEWS IN IMMUNOLOGY (2010)
The mechanism of action of β-D-2'-Deoxy-2'-fluoro-2'-C-methylcytidme involves a second metabolic pathway leading to β-D-2'-deoxy-2-fluoro-2'-C-methyluridine 5'-triphosphate, a potent inhibitor of the hepatitis C virus RNA-dependent RNA polymerase
Eisuke Murakami et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
HCV RNA-dependent RNA polymerase as a target for antiviral development
MP Walker et al.
CURRENT OPINION IN PHARMACOLOGY (2002)
Medical progress: Hepatitis C virus infection.
GM Lauer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
分享论文
